LOWER CHOLESTEROL LEVELS DO NOT CONFER PROTECTION FROM CORONARY ARTERY DISEASE IN HEPATITIS C

被引：0
|
作者：
Pothineni, N. K. [1 ]
Vallurupalli, S. [1 ]
Mehta, J. L. [1 ]
机构：
[1] Univ Arkansas Med Sci, Little Rock, AR 72205 USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2014年 / 62卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
476
引用
收藏
页码：549 / 549
页数：1
相关论文
共 50 条
  • [21] Statin use is associated with lower EPO levels in patients with coronary artery disease
    Van der Meer, R
    Asselbergs, FW
    Lipsic, E
    Tio, RA
    Voors, AA
    Van Veldhuisen, DJ
    Ziljstra, F
    Van Gilst, WH
    EUROPEAN HEART JOURNAL, 2004, 25 : 603 - 603
  • [22] Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease
    Johannesson, M
    Jonsson, B
    Kjekshus, J
    Olsson, AG
    Pedersen, TR
    Wedel, H
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (05): : 332 - 336
  • [23] Fibrinogen Beta Variants Confer Protection Against Coronary Artery Disease in a Greek Case-Control Study
    Dedoussis, George
    Theodoraki, Eirini V.
    Nikopensius, Tiit
    Suhorutsenko, Julia
    Peppes, Vassileios
    Fili, Panagiota
    Kolovou, Genovefa
    Zakopoulos, Nikolaos
    Richter, Dimitrios
    Metspalu, Andres
    CIRCULATION, 2010, 122 (02) : E365 - E365
  • [24] FIBRINOGEN BETA VARIANTS CONFER PROTECTION AGAINST CORONARY ARTERY DISEASE IN A GREEK CASE-CONTROL STUDY
    Theodoraki, E.
    Nikopensius, T.
    Suhorutsenko, J.
    Dimitriou, M.
    Peppes, V.
    Kolovou, G.
    Zakopoulos, N.
    Richter, D.
    Metspalu, A.
    Dedoussis, G.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 205 - 205
  • [25] Fibrinogen beta variants confer protection against coronary artery disease in a Greek case-control study
    Theodoraki, Eirini V.
    Nikopensius, Tiit
    Suhorutsenko, Julia
    Peppes, Vassileios
    Fili, Panagiota
    Kolovou, Genovefa
    Papamikos, Vassileios
    Richter, Dimitrios
    Zakopoulos, Nikolaos
    Krjutskov, Kaarel
    Metspalu, Andres
    Dedoussis, George V.
    BMC MEDICAL GENETICS, 2010, 11
  • [26] ASSOCIATION OF SERUM LIPOPROTEIN CHOLESTEROL LEVELS AND THE PRESENCE AND SEVERITY OF CORONARY-ARTERY DISEASE
    TEMKIN, LP
    EWY, GA
    CLINICAL RESEARCH, 1980, 28 (01): : A15 - A15
  • [27] Coronary Artery Disease with Elevated Levels of HDL Cholesterol Is Associated with Distinct Lipid Signatures
    Xia, Wanying
    Yu, Haiyi
    Wang, Guisong
    METABOLITES, 2023, 13 (06)
  • [28] Assessing HDL Metabolism in Subjects with Elevated Levels of HDL Cholesterol and Coronary Artery Disease
    Hancock-Cerutti, William
    Millar, John S.
    Valentini, Silvia
    Liu, Jason
    Billheimer, Jeffrey T.
    Rader, Daniel J.
    Cuchel, Marina
    MOLECULES, 2021, 26 (22):
  • [29] Determinants of postprandial lipemia in men with coronary artery disease and low levels of HDL cholesterol
    Syvanne, M
    Talmud, PJ
    Humphries, SE
    Fisher, RM
    Rosseneu, M
    Hilden, H
    Taskinen, MR
    JOURNAL OF LIPID RESEARCH, 1997, 38 (07) : 1463 - 1472
  • [30] Remnant-like particle cholesterol levels in patients with dysbetalipoproteinemia or coronary artery disease
    Devaraj, S
    Vega, G
    Lange, R
    Grundy, SM
    Jialal, I
    AMERICAN JOURNAL OF MEDICINE, 1998, 104 (05): : 445 - 450
12345